Growing Clinical Opportunity
More compounds in pre-clinical
Increased pressure to move quickly to clinical
More emphasis on Phase I (exploratory development) and Phase IV
Increased clinical development outsourcing
CRL clinical well established to capitalize on growth in biotech sector
Continued focus on delivery to large pharma customers